Mitachi Sangyo revised upward its consolidated earnings forecast for the fiscal year ending May 2027. Chiome announced the results of joint research, providing a catalyst for its share price. TRAAS ON PRODUCT announced an order for a DX solution.
After the close of trading on the 16th, Mitachi Sangyo revised upward its consolidated earnings forecast for the fiscal year ending May 2027, raising revenue from ¥110.0 billion to ¥115.0 billion, operating profit from ¥1.8 billion to ¥2.35 billion, and net income from ¥1.5 billion to ¥1.9 billion. The company said sales in Japan and overseas in the automotive sector remained firm, as did EMS orders in the industrial equipment sector. The shares rose sharply for a second consecutive session on the news.
Chiome Bioscience announced that the results of its joint research with the Department of Infectious Pathology at the National Institute of Infectious Diseases had been published in the international journal Proteins Science. The company said the findings could lead to a new approach to antigen design aimed at realizing a universal vaccine. The paper indicates the possibility of inducing antibodies that react to multiple strains through molecular mimicry using anti-idiotype antibodies targeting influenza viruses.
TRAAS ON PRODUCT announced that it had received an order for its AI-powered labor-saving DX solution, the Sorting DX System. The order value is ¥17 million, excluding tax, and delivery is scheduled for January 2027.